Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With CKD and Type 2 Diabetes

被引：0
|
作者：
Fu, Edouard [1 ,2 ]
D'Andrea, Elvira [1 ,2 ]
Wexler, Deborah J. [2 ,3 ]
Patorno, Elisabetta [1 ,2 ]
Paik, Julie M. [1 ,2 ]
机构：
[1] Brigham & Womens Hosp, Boston, MA USA
[2] Harvard Med Sch, Boston, MA USA
[3] Massachusetts Gen Hosp, Boston, MA USA
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2022年 / 33卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
SA-PO260
引用
收藏
页码：673 / 673
页数：1
相关论文
共 50 条
  • [41] Cardiovascular outcomes of sodium glucose cotransporter-2 inhibitors in patients with type 2 diabetes
    Dawwas, Ghadeer K.
    Smith, Steven M.
    Park, Haesuk
    DIABETES OBESITY & METABOLISM, 2019, 21 (01): : 28 - 36
  • [42] Association of Sodium-Glucose Cotransporter-2 Inhibitors With Fracture Risk in Older Adults With Type 2 Diabetes
    Zhuo, Min
    Hawley, Chelsea E.
    Paik, Julie M.
    Bessette, Lily G.
    Wexler, Deborah J.
    Kim, Dae H.
    Tong, Angela Y.
    Kim, Seoyoung C.
    Patorno, Elisabetta
    JAMA NETWORK OPEN, 2021, 4 (10)
  • [43] Sodium-glucose cotransporter-2 inhibitors and risk for genitourinary infections in older adults with type 2 diabetes
    Varshney, Navya
    Billups, Sarah J.
    Saseen, Joseph J.
    Fixen, Cy W.
    THERAPEUTIC ADVANCES IN DRUG SAFETY, 2021, 12
  • [44] Heterogenous effects of sodium-glucose cotransporter-2 inhibitors on nephrolithiasis in older adults with type 2 diabetes
    Li, Yujia
    Shao, Hui
    Guo, Yi
    Zhang, Yongkang
    Fonseca, Vivian
    Shi, Lizheng
    Bian, Jiang
    Winterstein, Almut G.
    Guo, Serena Jingchuan
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 12 - 13
  • [45] The Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors in Reducing Uric Acid in Type 2 Diabetes Mellitus
    Dong, Meiyuan
    Chen, Huiling
    Wen, Song
    Yuan, Yue
    Yang, Liling
    Xu, Dongxiang
    Zhou, Ligang
    DIABETES METABOLIC SYNDROME AND OBESITY, 2023, 16 : 437 - 445
  • [46] Use of sodium-glucose cotransporter-2 inhibitors and urinary tract infections in type 2 diabetes patients: a systematic review
    Figueiredo, Izabela Rodrigues
    Paes Rose, Sara Cardoso
    Freire, Nathalia Bandeira
    Patrocinio, Marina Stabile
    Pierdona, Natalia
    Bittencourt, Roberto Jose
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2019, 65 (02): : 246 - 252
  • [47] Effects of sodium-glucose cotransporter-2 inhibitors on cardiovascular outcomes in patients with atrial fibrillation and type 2 diabetes mellitus
    Oh, Y. S.
    Choi, Y.
    Kim, S. H.
    Kim, S. H.
    Park, S. Y.
    Kim, H. J.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [48] Impact of Sodium-Glucose Cotransporter-2 Inhibitors on Heart Failure in Patients With Type 2 Diabetes Mellitus: A Systematic Review
    Abdelhady, Hala A.
    Abakar, Adoum Oumar
    Gangavarapu, Ravindra Reddy
    Mahmud, Sayed A.
    Manandhar, Anura
    Sabir, Ghadeer
    Malasevskaia, Iana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (09)
  • [49] Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure With Preserved Ejection Fraction and Type 2 Diabetes
    Fu, Edouard L.
    Patorno, Elisabetta
    Everett, Brendan
    Vaduganathan, Muthiah
    Solomon, Scott
    Levin, Raisa
    Schneeweiss, Sebastian
    Desai, Rishi
    CIRCULATION, 2022, 146
  • [50] IMPACT OF SODIUM-GLUCOSE COTRANSPORTER-2 INHIBITORS ON CARDIAC REMODELLING IN LOW RISK PATIENTS WITH TYPE 2 DIABETES MELLITUS
    Del Giudice, Carmen
    Fabiani, Dario
    Malvezzi, Marco Caracciolo D'aquino
    Scognamiglio, Gabriella
    Pezzullo, Enrica
    Caso, Valentina
    Castagnola, Patrizia
    Volpe, Alessandra
    Liccardo, Biagio
    Nigro, Gerardo
    Golino, Paolo
    Russo, Vincenzo
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2022, 24
12345